HPV Self-sampling in the General Population

Launched by INTERNATIONAL AGENCY FOR RESEARCH ON CANCER · Dec 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying different ways to screen for cervical cancer in women aged 30 to 65 living in certain areas of France. Researchers want to find out which method is most effective: sending a kit to collect samples at home (called "Outreach"), giving women the choice to either collect their own sample or have a healthcare provider do it (called "Choice"), or using the usual screening method (the "control" group). The goal is to make cervical cancer screening more accessible and effective.

To participate, women must be between 30 and 65 years old and living in the Marne or Aube departments of France. They also need to be at moderate risk for cervical cancer, meaning they are eligible for the organized screening program and are receiving their first invitation for this round of screening. Women who have had a total hysterectomy, a history of cervical cancer, or are currently being monitored for abnormal results or lesions will not be able to join. If eligible, participants can expect to be part of one of the three screening methods and help researchers learn how to improve cervical cancer prevention for others in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women aged 30 to 65 years old
• • Living in the study area (Departments of Marne and Aube, France)
• • At moderate risk of cervical cancer, i.e. eligible to the organised programme and receiving the first invitation of the screening round (not a reminder letter)
• Exclusion Criteria:
• • Outside the target age (less than 30 years old, or 66 years old and more)
• • Already participating in the current screening round
• • Total hysterectomy
• • History of cervical cancer
• • Current follow-up for abnormal cervical screening result or cervical lesions